Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA PFIZER AUROBINDO PHARMA/
PFIZER
 
P/E (TTM) x 12.9 34.3 37.8% View Chart
P/BV x 1.1 7.3 15.3% View Chart
Dividend Yield % 1.9 0.8 251.2%  

Financials

 AUROBINDO PHARMA   PFIZER
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
PFIZER
Mar-22
AUROBINDO PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0646,165 17.3%   
Low Rs5844,163 14.0%   
Sales per share (Unadj.) Rs400.3570.7 70.1%  
Earnings per share (Unadj.) Rs45.7133.9 34.1%  
Cash flow per share (Unadj.) Rs64.9159.0 40.8%  
Dividends per share (Unadj.) Rs9.0035.00 25.7%  
Avg Dividend yield %1.10.7 161.1%  
Book value per share (Unadj.) Rs419.4626.1 67.0%  
Shares outstanding (eoy) m585.9445.75 1,280.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.19.0 22.8%   
Avg P/E ratio x18.038.6 46.7%  
P/CF ratio (eoy) x12.732.5 39.1%  
Price / Book Value ratio x2.08.2 23.8%  
Dividend payout %19.726.1 75.3%   
Avg Mkt Cap Rs m482,799236,225 204.4%   
No. of employees `000NANA-   
Total wages/salary Rs m34,5094,037 854.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,55526,110 898.3%  
Other income Rs m3,226627 514.9%   
Total revenues Rs m237,78126,736 889.4%   
Gross profit Rs m42,5668,359 509.2%  
Depreciation Rs m11,2651,150 979.6%   
Interest Rs m486107 454.6%   
Profit before tax Rs m34,0407,729 440.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2561,603 452.6%   
Profit after tax Rs m26,7846,126 437.2%  
Gross profit margin %18.132.0 56.7%  
Effective tax rate %21.320.7 102.8%   
Net profit margin %11.423.5 48.7%  
BALANCE SHEET DATA
Current assets Rs m181,22723,965 756.2%   
Current liabilities Rs m81,5608,529 956.3%   
Net working cap to sales %42.559.1 71.9%  
Current ratio x2.22.8 79.1%  
Inventory Days Days2586 29.1%  
Debtors Days Days622 3,594.0%  
Net fixed assets Rs m155,10414,571 1,064.5%   
Share capital Rs m586458 128.1%   
"Free" reserves Rs m245,17428,187 869.8%   
Net worth Rs m245,76028,644 858.0%   
Long term debt Rs m2,4920-   
Total assets Rs m336,33138,535 872.8%  
Interest coverage x71.073.2 96.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.7 102.9%   
Return on assets %8.116.2 50.1%  
Return on equity %10.921.4 51.0%  
Return on capital %13.927.4 50.8%  
Exports to sales %31.13.0 1,038.1%   
Imports to sales %11.92.5 477.7%   
Exports (fob) Rs m72,862781 9,325.8%   
Imports (cif) Rs m27,965652 4,291.7%   
Fx inflow Rs m77,245781 9,886.7%   
Fx outflow Rs m31,524652 4,837.9%   
Net fx Rs m45,721130 35,251.7%   
CASH FLOW
From Operations Rs m50,1656,671 752.0%  
From Investments Rs m-32,116-5,750 558.5%  
From Financial Activity Rs m-29,693-1,805 1,644.9%  
Net Cashflow Rs m-11,674-885 1,319.8%  

Share Holding

Indian Promoters % 48.8 0.0 -  
Foreign collaborators % 3.1 63.9 4.8%  
Indian inst/Mut Fund % 38.0 17.4 217.8%  
FIIs % 21.4 2.6 839.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 36.1 133.5%  
Shareholders   358,459 122,028 293.8%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Aurobindo Pharma vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Pfizer Share Price Performance

Period Aurobindo Pharma Pfizer S&P BSE HEALTHCARE
1-Day 0.25% 0.80% -0.10%
1-Month -15.66% 2.64% -1.99%
1-Year -30.20% -6.92% -5.62%
3-Year CAGR 1.45% 3.08% 20.96%
5-Year CAGR -6.95% 19.05% 11.47%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Pfizer paid Rs 35.0, and its dividend payout ratio stood at 26.1%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.